Nanoparticle Formulation : SOP for Preparation of Magnetic Nanoparticles for Biomedical Applications

SOP for Preparation of Magnetic Nanoparticles for Biomedical Applications

Standard Operating Procedure for Preparation of Magnetic Nanoparticles for Biomedical Applications

1) Purpose

This SOP outlines the procedure for the preparation of magnetic nanoparticles used in biomedical applications, such as targeted drug delivery, magnetic resonance imaging (MRI), and hyperthermia treatment.

2) Scope

This SOP applies to laboratory personnel involved in the preparation and characterization of magnetic nanoparticles for biomedical use.

3) Responsibilities

  • Operators: Responsible for preparing magnetic nanoparticles following the outlined protocol.
  • QA: Ensures the prepared nanoparticles meet the required specifications for size, magnetic properties, and biocompatibility.
See also  Nanoparticle Formulation : SOP for Lyophilization of Nanoparticle-Based Formulations

4) Procedure

4.1 Preparation of Magnetic Nanoparticles

4.1.1 Material Selection

  • 4.1.1.1 Select suitable magnetic materials, such as iron oxide (Fe3O4 or Fe2O3), for nanoparticle synthesis.
  • 4.1.1.2 Ensure that all materials are of high purity and suitable for biomedical applications.

4.2 Synthesis of Magnetic Nanoparticles

4.2.1 Co-Precipitation Method

  • 4.2.1.1 Dissolve ferric chloride (FeCl3) and ferrous chloride (FeCl2) in water at a 2:1 molar ratio under nitrogen atmosphere.
  • 4.2.1.2 Add ammonium hydroxide (NH4OH) dropwise under constant stirring to precipitate magnetic nanoparticles.
  • 4.2.1.3 Continue stirring for 30 minutes to ensure uniform particle formation.

4.3 Surface Functionalization

4.3.1 Coating with Biocompatible Materials

  • 4.3.1.1 Coat the magnetic nanoparticles with a biocompatible material such as PEG, dextran, or silica to enhance their stability and compatibility with biological systems.
See also  Nanoparticle Formulation : SOP for Preparation of Nanoparticles for Nasal Delivery

4.3.2 Ligand Attachment

  • 4.3.2.1 Attach
specific targeting ligands (e.g., antibodies, peptides) to the surface of the nanoparticles for targeted biomedical applications.

4.4 Particle Size and Magnetic Property Characterization

4.4.1 Dynamic Light Scattering (DLS)

  • 4.4.1.1 Measure the size and distribution of magnetic nanoparticles using DLS.

4.4.2 Magnetic Measurements

  • 4.4.2.1 Use a vibrating sample magnetometer (VSM) or similar equipment to measure the magnetic properties (e.g., saturation magnetization, coercivity) of the nanoparticles.

4.5 Storage

4.5.1 Storage Conditions

  • 4.5.1.1 Store the magnetic nanoparticles in sealed containers at 4°C or room temperature, depending on their stability and intended application.

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering
  • VSM: Vibrating Sample Magnetometer
  • PEG: Polyethylene Glycol

6) Documents, if any

  • Magnetic Nanoparticle Preparation Logbook

7) References, if any

  • Relevant literature on magnetic nanoparticles for biomedical applications

8) SOP Version

Version 1.0

Annexure

Magnetic Nanoparticle Preparation Logbook Template

Date Batch Number Material Used Particle Size Magnetic Properties Operator Initials QA Initials
DD/MM/YYYY Batch Number Material (e.g., Fe3O4) Size in nm Magnetic Properties Operator Name QA Name
           
See also  SOP for Preparation of Metal Nanoparticles

Related Posts